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1. IntroductIon 
Psoralea corylifolia has long been used in 
traditional Ayurvedic and Chinese medicine. This plant 
is   pharmacologically studied for its chemoprotective, 
antioxidant, anti-microbial, and anti-inflammatory properties. 
The plant of immense biological importance has been 
exploited since ages against several skin diseases, such 
as psoriasis, leukoderma, and leprosy1. The trade name 
of Psoralea corylifolia is babchi and bakuchi2. The plant 
possesses potent inhibitory activity against 4 species of fungi 
viz. Trichophyton rubrum, Trichophyton mentagrophytes, 
Epidermophyton floccosum and Microsporum gypseum3,4. 
The active compound (+) bakuchil 1 exhibited anti-tumoral 
property in vitro5. The pure compound 6-(3-methyl but -2-enyl) 
6-7 dihydroxy coumestan 1 isolated from chloroform extract 
of the seed of Psoralea corylifolia L. was evaluated for the 
pesticidal activity against both adults and different instars of 
Tribolium casteneum Hebrst6. The chloroform extract of seed 
was effective against carrageen induced paw edema in rat and 
mouse ear inflammation7, anti-helmintic activity using two-
enzyme system taking rat brain as a model for Ascaridia galli8. 
The aqueous extract of seed furnished one hepatoprotective 
compound, bakuchiol 1, together with two moderately active 
compounds, bakuchicin 2 and psoralen 3, on tacrine-induced 
cytotoxicity in human liver- derived Hep G-2 cells9. The 
fruit extracts exhibited osteoblastic proliferation stimulating 
activity. Corylin and bavachin compounds from  Psoralea 
corylifolia  might stimulate bone formation and have potential 
activity against osteoporosis10. These phenolic compounds in 
Psoralea corylifolia were shown to be effective in protecting 
biological membranes against various oxidative stresses11. 
Bioassay directed purification of the active compounds led 
to the isolation of the new compound corylifolin 1 and the 
known compounds led to the isolation of the new compound 
bakuchiol 2 as DNA polymerase inhibitors12. 
The seed of Psoralea corylifolia has significant 
medicinal properties and is a rich source of isoflavones, 
daidzein (40, 7-dihydroxyisoflavone) and genistein (40, 5, 7 
trihydroxyisoflavone). In view of the action of natural dietary 
estrogens, they are recognised as potentially health-protective 
food compounds, which provide health benefits, including 
the prevention of sex hormone related ailments, cancer and 
cardiovascular diseases13. Isoflavones also exert antioxidant 
properties thereby provide protective effect against oxidative 
damage14,15 and they are used in the treatment of various skin 
diseases. Traditionally, the plant is used both internally as well 
as externally. The seed oil is extremely beneficial, externally 
in numerous skin ailments. Seeds yield essential oil, psoralen, 
resin, a terpenoid oil, isopsoralen and psoralidin. Seeds also 
contain a crystalline solid, a furocoumarin, from the pericarp, 
psoralidin and isopsoralen have been identified. Psoralen are 
active principle for inducing pigmentation13,16-17,19.
The depression criteria has gradually developed as 
documented by both the American Psychiatric Association 
(Diagnostic and Statistical Manual of Mental Disorders, 
DSM- IV, 1994) and the World Health Organisation 
Geneva (International Classification of Diseases, ICD-10, 
1993), providing essential guidance for both clinicians and 
researchers.
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AbstrAct 
The mouse forced swimming test (FST) and tail suspension test (TST) are widely used to predict anti-depressant 
efficacy indicated by immobility time to be reduced by several different classes of anti-depressant drugs. PCE feeding 
at the dose of 75 mg/kg,150 mg/kg, and 300 mg/kg reduced the immobility duration at 14-days and 21-days, however 
the decrease was significant in mice treated with PCE for 21-days also, extract had no effect on spontaneous motor 
activity in mice, indicating that extract had no excitatory or inhibitory action on central nervous system in effective 
dose range, which eliminated the probability of false-positive results in forced swimming test and tail suspension 
test. Interestingly, the dose-response effect of PCE on reduction of serum CRF levels was concomitance with that 
on increase of brain 5-HT contents, as well as on swimming increase, indicating that the serotonergic system and 
the HPA axis responds with the production of 5-HT and CRF profiles that is characteristic for PCE applied in the 
mouse FST. Our results demonstrate that the oral administration of PCE possesses an anti-depressant-like activity, 
as evidenced by behavioural studies. Detailed investigations are needed to fully elucidate the mechanism of action 
at cellular level for the bioactive constituents present in the extract. 
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2. MAtErIAls And MEthods
2.1 Materials
2.1.1  Plant Materials and Extraction
The Psoralea corylifolia seeds purchased from local 
market was powdered and soaked in absolute alcohol for 24 
h at room temperature and allowed to constant shaking using 
mechanical shaker. After 24 h, the seeds were filtered through 
filter paper in order to collect the extract of psoralea. The seeds 
were again soaked in absolute ethanol for 24 h and the process 
of soaking and filtration was repeated till the colour of the seed 
is fainted. The filtrate collected in a flask was concentrated in 
the rotary flash evaporator. Sufficient extracts were prepared 
by this method for chemical and biochemical evaluation.
2.2 Methods
2.2.1 Experimental Animals
The animal experiments, male Balb/c mice weighing 
about 20 g - 25 g were used. These mice had free access to 
laboratory feed and water under standard laboratory conditions. 
The animals used in the present study were maintained 
in accordance with the guidelines of National Institute of 
Nutrition, India and approved by Institutional Animal Ethics 
Committee (IAEC). Experiments was carried out between 1 
pm - 3 pm For the behavioral test, different doses of the extract 
were separately suspended in a vehicle comprising 1% (w/v) 
tween 20 in distilled water and a standard drug (amitriptyline 
and fluoxetine) were given by gastric gavage once a day over a 
period of 1 day, 3 days, 7 days, 14 days, and 21 days. Behavioral 
test was conducted 1 h after the last treatment/administration.
2.2.2 Forced swimming Test
48 mice were randomly divided into 6 groups comprising 
of 8 mice in each group (Table 1.) and treated as follows: 
Group 1 served as normal control and group 2 received tween-
80 suspensions and served as experimental control (FST 
group). Group 3-5 were orally administered with various doses 
of PCE extract (75 mg, 150 mg, and 300 mg extract/kg of body 
weight) and group 6 and 7 received standard anti-depressant 
drug-amitriptyline and fluoxetine (10 mg/kg body weight). 
PCE extract was suspended in a vehicle comprising 
1 per cent (w/v) tween 20 in distilled water (75 mg, 150 mg, 
and 300 mg extract/kg of body weight).
The FST conducted in mice was same as that described 
by Bhattacharya and Satyan20. All the groups of mice were 
subjected to swimming test except group 1 in a cylindrical 
glass aquarium (20 cm x 14 cm diameter), containing 25±2 ºC 
water. Mice were allowed to swim for 6 min and the duration 
of immobility was measured during the final 4 min interval 
of the test using a video tracking system. Immobility period 
was regarded as the time spent by the mouse floating in the 
water without struggling and making only those movements 
necessary to keep its head above the water. Following 
swimming sessions, they were then towel dried. In order to 
determine the time-dependent effects on immobility time, oral 
treatments with PCE for 1 day, 3 days, 7 days, 14 days, and 21 
consecutive days were investigated. Animals were sacrificed 
on the last day of the experiment and bled between 1 pm - 3 pm 
to avoid the variation on the hormonal levels due to circadian 
rhythms. Blood was collected and plasma was separated in a 
refrigerated centrifuge at 4 °C.
2.2.3  Tail suspension Test 
Forty eight mice were randomly divided into 6 groups 
consisting of 8 mice in each groups as shown in Table 2 and 
treated as follow: Group 1 served as normal control and group 
2 received tween-20 suspensions (TST group). Group 3-5 
were orally administered with various doses of PCE extract 
suspended in a vehicle comprising 1 per cent (w/v) tween 20 
in distilled water (75 mg, 150 mg, and 300 mg extract/kg of 
body weight). Group 6 and group 7 received standard anti-
depressant drug-amitriptyline (10 mg/kg b.wt) and fluoxetine 
(10 mg/kg b.wt).
Animal groups treatment 
Group 1 Normal control
Group 2 Tween-20 suspensions + FST
Group 3 PCE (75mg/kg b wt.) + FST
Group 4 PCE (150mg/kg b wt.) + FST
Group 5 PCE (300mg/kg b wt.) + FST
Group 6 Amitriptyline (10mg/kg b wt.) + FST
Group 7 Fluoxetine (10mg/kg b wt.) + FST
table 1.  Experiment animal groups  
Animal groups treatment 
Group 1 Normal control
Group 2 Tween-20 suspensions + TST
 Group 3 PCE (75mg/kg b wt.) + TST
 Group 4 PCE (150mg/kg b wt.) + TST
Group 5 PCE (300mg/kg b wt.) + TST
Group 6 Amitriptyline (10mg/kg b wt.) + TST
Group 7 Fluoxetine (10mg/kg b wt.) + TST
table 2.  Experiment animal groups  
The procedure was employed as that described by Steru21, 
et al. with slight modifications. Briefly, a box with one side 
35 cm was used for the tail suspension test. The front surface 
of the apparatus was open and each mouse was suspended by 
fixing the tail in the centre of the upper surface using a tail 
hanger and non-irritant adhesive tape with the head 5 cm to 
the bottom. Testing was carried out in a darkened room with 
minimal background noise for duration of 6 min. The total 
duration of immobility (total immobility time) was observed 
and measured during the final 4 min interval of the test period. 
All test sessions were recorded by a video camera positioned 
directly above the box. Mice were considered immobile only 
when they hung passively and completely motionless.
2.2.4 Open Field Test  
Spontaneous motor activity was evaluated in open field 
test as per the method of Bhattacharya & Satyan20. The open 
field apparatus is made up of black plexi glass and consisted of 
a square 56 cm x 56 cm. The entire apparatus was divided the 
floor into 16 square of identical dimension. The entire room, 
except the open field was kept dark during the experiment. One 
hour after the treatment of vehicle/standard/extract, each animal 
was placed at one corner of the apparatus and the behavioural 
aspects were noted in the next 5 min. 
Open-field test shows the total distance travelled on 
the whole of the open-field arena by the mice. Though this 
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parameter does not reflect changes in emotional behavior, 
it is important for evaluating the total locomotor activity of 
the animals during the 5-min trial. The two major behavioral 
variables evaluated in the open field test were the time spent 
in the zone of the field and the number of line crossings across 
the entire zone. 
The open-field apparatus was a square, which was 
demarcated into 16 equal areas. The score locomotion (number 
of line crossings within 5 min) and rearing frequencies (number 
of times an animal stood on its hind legs) were recorded. This 
experiment, the animals received the same drugs and doses as 
those used when measuring immobility.
2.3 statistical Analysis
Data are shown as mean ± standard deviation. Comparison 
between groups was analyzed by ANOVA. The p values less 
than 0.05 were considered as significantly different.
3. rEsults And dIscussIon
Anti-depressant drugs have little or no effect in healthy 
individuals. The number of validated animal models for 
affective disorders is large and still growing. In addition, 
several minor variations have been applied to each model. A 
summary of the models can be found in several reviews4,22-24. 
The mouse forced swimming test and tail suspension test are 
widely used to predict anti-depressant efficacy indicated by 
immobility time to be reduced by several different classes of 
anti-depressant drugs21,25. The present study investigated the 
possible time dependent effects on immobility time.
3.1  Effect of PcE, Amitriptyline and Fluoxetine 
Pre-treatment on body Weight in Mice (Fst 
and tst Groups) 
The effect of extract on the body weight change is 
presented in Tables 3 and 4. Data shows that there is 
no difference in body weight gain among all the groups 
subjected to 1-day, 3-days and 7-days treatment, however 
there was a slight increase in weight in all groups at 
14 days and 21 days of oral administration. The weight 
gain of mice may be the normal weight gain of rats. It 
is confirmed that, administration of PCE did not have 
any effect on the weight of animals.
3.2 Effect of PcE, Amitriptyline and Fluoxetine 
Pre-treatment on Immobility time in the Mice 
(Fst and tst Groups)
In FST, mice are forced to swim in a restricted space from 
which they cannot escape and are induced to a characteristic 
behavior of immobility. This behavior, reflecting a state of 
despair is reduced by several agents which are therapeutically 
effective in human depression. The TST also induces a state of 
despair in animals like that in FST. This immobility, referred 
Table 3. Effect of PCE, amitriptyline and fluoxetine pre-treatment on body weight in mice (FST groups)
body weight (g) 
during different 
treatment period
(day(s))
Groups
Group 1
(control)
Group 2
(stress 
control)
Group 3
(75 mg/kg 
b.wt.)
Group 4
(150 mg/kgb.
wt.)
Group 5
(300 mg/kg 
b.wt.)
Group 6
(Amitriptyline 10 
mg/kg b.wt)
Group 7
(Fluoxetine 10 mg/
kg b.wt)
1 27.8±2.7 26.6±3.5 29.2±3.1 30.5±2.6 28.5.5±2.6 29.4±3.4 28.3±3.4
3  28.4±3.2 31.8±2.7 28.6±3.5 26.2±3.1 30.5±3.6 27.9±2.6 26.1±2.6
7  30.6±2.8 28.4±3.2 28.4±3.2 27.4±2.4 29.4±2.8 30.2±2.6 27.5±2.6
14  Initial 27.6±3.2 27.9±2.9 27.6±2.9 26.9±2.7 27.7±2.8 29.1±2.9 26.8±3.2
Final 31.5±2.9 30.4±3.1 30.1±3.0 29.5±2.6 31.3±2.3 31.7±3.1 29.7±2.6
21  Initial 28.4±2.2 28.9±2.5 27.3±3.4 26.2±3.1 29.5±3.2 29.9±2.6 28.1±3.2
Final 34.3±2.4 33.9±2.9 32.8±2.9 27.4±2.4 33.8±2.9 32.8±3.3 32.4±2.8
Values are presented as the mean ± SD (n=8). There were no significant differences at p<0.05.
  
body weight 
(g)
(day(s))
Groups
Group 1
(control)
Group 2
(stress control)
Group 3
(75 mg/kg 
b.wt.)
Group 4
(150 mg/kg 
b.wt.)
Group 5
(300 mg/kg 
b.wt.)
Group 6
(Amitriptyline 
10 mg/kg b.wt)
Group 7
(Fluoxetine 10 
mg/kg b.wt)
1  26.4±2.6 27.8±3.2 29.5±2.9 27.8±2.4 29.8±2.4 26.5±3.1 26.3±3.4
3  27.4±3.1 29.7±2.9 28.4±2.4 28.7±2.8 27.6±3.2 26.8±2.8 26.1±2.6
7  27.5±2.8 27.5±2.7 29.3±3.3 29.4±3.1 28.4±2.3 28.7±2.7 27.4±2.3
14 Initial 28.7±2.7 28.5±3.3 28.7±2.4 27.9±2.3 26.5±2.9 26.8±3.2 27.3±3.1
Final 30.4±3.1 31.7±3.0 31.5±2.6 29.4±2.5 29.7±2.2 29.7±2.6 30.4±2.9
21 Initial 26.4±2.2 26.8±2.9 27.8±3.4 27.4±3.3 30.5±3.1 28.1±3.2 28.2±3.4
Final 29.3±2.1 29.4±2.5 31.1±2.7 33.4±3.4 34.6±3.1 32.4±2.8 31.4±3.5
Values are presented as the mean ± SD (n=8). There were no significant differences at p<0.05.
Table 4.  Effect of PCE, amitriptyline and fluoxetine pre-treatment on body weight in mice (TST groups)
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to as behavioral despair in animals is claimed to reproduce a 
condition similar to human depression21,22.
To investigate possible time-dependent effects on 
immobility time, oral treatments with PCE for 1 day and 3, 
7, 14 and 21 consecutive days respectively were investigated 
under the standardized application schedule preceded by the 
appropriate vehicle control application.
A reduction in the duration of immobility of animals in 
the FST reflects their anti-depressant-like performance. PCE 
administration showed a significant activity to reduce the 
immobility time at doses of 7 mg/kg, 150 mg/kg, and 300 
mg/kg in forced swimming test in dose dependent manner 
in mice. The effects of PCE, amitriptyline and fluoxetine on 
immobility in mice FST are presented in Table 5 and TST are 
presented in table 5.6. respectively. Considering that clinical 
anti-depressant effects often appear after chronic treatment, 
PCE was administrated orally for 1 day and consecutively 
for 3 days, 7 days, 14 days and 21 days respectively for the 
investigation of the anti-depressant-like property in mice in 
FST and TST. In these models, PCE there slight decrease in 
immobility time after 3 days and 7 days treatment and the 
decrease was non-significant at p<0.05. The mice subjected to 
swimming after PCE pre-treatment for 14 days and 21 days 
there was a reduction in the duration of immobility compared 
with stress control and the effect was observed with the classical 
anti-depressant drug fluoxetine and amitriptyline.
PCE at 300 mg/kg b. wt. exhibited significant decrease in 
immobility duration after oral treatment for 14-days. After 21-
days treatment of PCE, there was a significant treatment effect 
for dose in immobility time. The maximal effect was observed 
at 300 mg/kg b.wt. with marked reduction in immobility time 
was observed in reference with anti-depressants amitriptyline 
and fluoxetine.
The effect of PCE, amitriptyline and fluoxetine immobility 
time in the mice TST are presented in Table 6. There was no 
significant change of immobility time in the mouse subjected 
to TST and pre-treated with PCE for 1-day and 3-days at the 
doses from 75and 150 mg/kg .wt. however, there was a slight 
decrease in immobility in treated groups at 300mg/kg b.wt. PCE 
produced a decrease in immobility time after 7-day treatment; 
300mg/kg b.wt was effective in reducing the time period. 
After 14-days and 21-days treatment, PCE also significantly 
exhibited in reducing the duration of immobility at 75, 150 and 
300 mg/kg. PCE at 300 mg/kg b.wt. showed maximal effect in 
TST behavioural in mice. Fluoxetine and amitriptyline resulted 
in a significant reduction at 10mg/kg b.wt. 
FST model is valid for a broad spectrum of anti-depressants 
mainly including tricyclics and monoamine oxidase inhibitors, 
which significantly decrease immobility time4. When subjected 
to unavoidable stress mice display of immobility is thought 
to reflect a state of despair or lowered mood, which reflects 
depressive illness in humans. It is also assumed that animals 
have given up the hope of escaping from the restricted area. It 
has been reported that anti-depressant drugs have the ability to 
reduce this immobility period in animal model26,27. The present 
results showed that PCE, when administered orally was 
Group dosemg/kg b.wt
duration of immobility (s) 
1 day 3 days 7 days 14 days 21 days
Group 1 (Control) - - - - - -
Group 2 (Stress control) - 115.2±12.3 105.0±10.3 110.6±10.3 105.1±13.1 108.6±9.9
Group 3 75 105.1±8.6 89.9±6.6a 92.7±7.6 75.4± 08.1a 68.2±7.6a
Group 4 150 99.9±12.6 88.4±8.3a 78.6±4.3a 61.7±05.0a 59.8±6.7a
Group 5 300 89.5±6.1a 74.0±5.9b 66.9±6.7b 43.8±09.0b 23.7±5.6b
Group 6 (Amitriptyline) 10 74.0±5.9b 64.1±10.5c 57.5±8.1c 30.0±12.4b 15.4±7.9c
Group 7 (Fluoxetine) 10 81.0±13.6a 69.7±8.7b 64.8±5.6b 37.0±06.6c 28.4±7.2b
Values are presented as the mean ± SD (n=8). Values bearing different superscripts in the same column are significantly different (p<0.05) (ANOVA).
Table 5. Effect of PCE, amitriptyline and fluoxetine pre-treatment on immobility time in the mice (FST groups)
Group
dose duration of immobility (s) 
mg/kg b.wt. 1 day 3 days 7 days 14 days 21 days
Group 1 (Control) -  - - - - -
Group 2  (Stress control) - 98.1±8.9 97.4±10.3 102.4± 8.7 99.7±10.1 101.3±12.4
Group 3 75 90.5±8.6 91.4±8.9 87.7± 6.7a 77.6±8.8a 71.5±9.2a
Group 4 150 89.9±12.6 83.2±7.2 80.6± 7.6a 69.8±7.6a 62.7±7.9a
Group 5 300 89.6±6.1 74.5±8.4a 71.8± 6.7b 59.4±8.1b 54.7±9.3b
Group 6 (Amitriptyline) 10 84.0±5.9 68.7±11.1a 62.4±10.4b 52.7±10.4b 47.4±8.9b
Group 7 (Fluoxetine) 10 82.8±13.6 73.4±7.6a 67.5±9.7b 54.0±6.6b 49.4±5.9b
Values are presented as the mean ± SD (n=8). Values bearing different superscripts in the same column are significantly different (p<0.05) (ANOVA).
Table 6. Effects of PCE, amitriptyline and fluoxetine pre-treatment on the duration of immobility in the mice (TST groups)
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effective in producing significant anti-depressant-like 
effects in these models. On the immobility behavioral 
measure, PCE showed clear dose-response pattern 
among the treatment period in the mouse FST. The 
positive anti-depressant amitriptyline and fluoxetine 
was significant effective after 7 days, 14 days and 
21 days treatment. The present study showed that 
administration of PCE for 14 days and 21 days could 
significantly reduce the immobility time in FST and 
TST models compared to stress control in a dose-
dependent manner.
3.3 Effect of PcE Pre treatment on 
locomotor Activity
To detect any association of immobility in the 
FST and TST with changes in motor activity, the 
locomotor behaviours of animals treated with PCE 
were tested in an open field. Open field test was 
arranged to avoid the effects on locomotor activity 
caused by central nervous system stimulants. The 
results showed that all the doses in FST and TST did not 
significantly change locomotor activity.
Table 7 shows the results obtained with open field test. 
The treatment of animals with 14 days and 21 days showed 
no differences compared with control animals in the number 
of crossing and rearing in the 5 min open field test at the dose. 
Open-field test shows the total distance travelled in the whole 
of the open-field arena by the mice. Though this parameter 
does not reflect changes in emotional behavior, it is important 
for evaluating the total locomotor activity of the animals 
during the 5 min trial. The two major behavioral variables 
evaluated in the open field test were the time spent in the 
zone of the field and the number of line crossings across the 
entire zone. Novel object test model investigates the approach 
avoidance behaviors of mice in response to novel stimuli28. 
In FST and TST, false-positive results can be obtained 
with certain drugs in particular psychomotor stimulants, 
which decrease immobility time by stimulating locomotor 
activity29. Changes in the duration of immobility could also 
result from effects on locomotor activity caused by central 
nervous system stimulants the mice were tested in the open 
field test just before FST. The results showed that PCE, at 
the given dose (300 mg/kg b.wt.) produced an anti-depressant 
like effect, did not significantly change locomotor behavior. 
Therefore PCE appears to produce a specific anti-depressant-
like behavioral effect and was not associated with the 
locomotor effects.
The present investigation demonstrated the anti-
depressant activity in behavioral despair models of animals 
viz. forced swimming test  and tail suspension test  the  widely 
used models to predict anti-depressant efficacy indicated by 
immobility time. Detailed investigations are needed to fully 
elucidate the mechanism of action at cellular level for the 
bioactive constituents present in the extract. Further pre-
clinical and clinical studies seem warranted to assess in more 
detail possible anti-depressant effects of Psoralea corylifolia, 
and their therapeutic role in the treatment of depression.
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Values are presented as the mean ± SD (n=8). There were no significant differences at p<0.05.
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